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The reported inability to establish long-term T -cell lines 
fro m the blood of cutaneous T -cell lymphoma patients with 
circulating neoplastic T cells has hindered the development 
of an in vitro system to investigate Sezary syndrome. We 
have established a rapidly proliferating T -cell line from the 
peripheral blood of a patient with Sezary syndrome, 
S ezary syndrome, a leukemic variant of cutaneous T-cell lymphoma (CTCL), is an intermediate-grade malignant lymphoma characterized by generalized erythroderma, lymphadenopathy, and the presence ofT lymphocytes with cerebriform nuclei in the peripheral blood [1] . With 
a single exception [1], attempts to establish T-cell lines from pa-
tients with HTL V-I- negative Sezary syndrome have been unsuc-
cessful [2 - 7]. For reasons not well understood, Sezary T-celllines 
cannot be generated using experimental conditions that are suffi-
cient for the propagation of CD4-positive cell lines from healthy 
donors. This apparent defect may be due to an inability of Sezary 
cells to be activated by conventional cell mitogens and/ or a require-
ment for growth factors distinct from interleukin-2 (IL-2) [7] . 
By combining a factor produced by peripheral blood mononu-
clear cells (PBMC) ofSezary syndrome patients and recombinant (r) 
IL-2, we have established an IL-2-responsive, continuously grow-
ing T -cell line with structural and genetic characteristics of neo-
plastic Sezary cells. 
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which expresses a mature helper T-cell phenotype and con-
tains cytogenetic abnormalities and T -cell receptor gene 
rearrangements identical to those in the patient's blood. The 
method of establishment and characteristics of this line are 
described.] I11vest D erma tol96:31-37, 1991 
MATERIALS AND METHODS 
Patient Description Sezary patient number 4 (SZ-4), a 66-year-
old black woman who lived in Philadelphia aU her life , presented in 
May 1984 with numerous irregularly shaped patches and slightly 
infiltrated plaques disseminated over the trunk and extremities. The 
patient also had enlarged (1-2-cm-diameter) lymph nodes in both 
axillae and no other signs of extracutaneous involvement. Histo-
pathologic findings on a skin biopsy specimen were diagnostic for 
an epidermotropic form of CTCL; immunohistochemistry, using 
parallel sections, demonstrated that the predominant T cell ex-
pressed an aberrant helper phenotype (CD2- , CD3+, CD4+, 
CDS+, CD7-, CD8-) with high expression of some but not all 
activation markers (HLA DR~, CD25+ , and CD30-). A lymph 
node removed from the left axill a showed dermatopathic lympha-
denitis and the remainder of the staging evaluation was unremark-
able, although a few small Sezary-like cells (7 cells/100 lympho-
cytes) were identified on blood smears. Thus, the patient was 
considered to have plaque-phase mycosis fungoides at stage lla (T2 
N1 BO MO). Despite systemic chemotherapy and oral methoxsalen 
combined with long-wave ultraviolet radiation, the patient's skin 
became diffusely eczematous by October 1985. In November 1986, 
lymph-node biopsy revealed diffuse effacement of nodal architec-
ture, with relatively small irregularly shaped lymphocytes express-
ing identical phenotype as that observed in skin biopsy. Her disease 
was staged at IVa (T4 N3 Bl MO). 
In October 1987, the patient died with extensive lymphomatous 
involvement. Permission for an autopsy was not obtained. 
Establishment and Cultnre of the T-Cell Line Blood was 
obtained for establishing a cell line in September 1986. PBMC were 
recovered from heparinized blood from SZ-4 by Ficoll-Hypaque 
density centrifugation (Phamacia, Piscataway, NJ). 20 X 106 cells 
were placed in media containing 15 U/ml recombinant r-IL-2, 
(Amgen, Thousand Oaks, CA) and 10% conditioned media (CM) 
from concanavalin A (Con A; Sigma, St. Louis, MO)-treated Se-
zary PBMC. The culture was fed 2-3 times per week with media 
containing riL-2, split at a 1:2 ratio w hen necessary, and allowed to 
grow. When culture growth slowed, as determined by tri tiated 
thymidine incorporation and by viable cell counts, the cells were 
restimulated. Restimulation consisted of addition of either CM 
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alone or CM and gamma-irradiated random allogeneic PBMC. Typ-
ically, the line required restimulation every 3 months for the first 
year of culture. 
Conditioned Media (CM) PBMC recovered from another Se-
zary patient (SZ-1) were cultured at 4 X 106/ ml with 2,ug/ml Con 
A for 48 h; the supernatant was then collected. One milligram per 
milliliter alpha-methyl mannoside (Sigma) was added to inhibit 
Con A activity. CM was used at 0.2% final concentration. 
Culture Medium Cells were cultured in 15% fetal bovine serum 
(Flow, McLean, VA), 2% L-glutamine (Gibco, Grand Island , NY), 
2% penicillin-streptomycin (Hazelton, Lenexa, KS), 0.5% Hepes 
buffer (Hazelton) , 0.2% gentamycin (Sigma), and 15 U /ml riL-2 in 
RPMl 1604 (Hazelton). 
Phenotypic Analysis The expression of cell-surface antigens 
was analyzed by examining the reactivity of the cell line with mouse 
anti-human leuckocyte monoclonal antibodies (MoAb) whose bind-
ing was revealed with a FITC-conjugated goat anti-mouse IgG 
(Cappel, Malvern, PA). MoAb against CD2, CD3, CD4, CD8, 
CD15, CD16, and CD20 were the gifts of Dr. Georgia Trinchieri, 
Wistar Institute; anti-CD7 was a gift from Drs . Tom Palker and 
Bart Haynes (Duke University, Durham, NC); monoclonals spe-
cific for CDS, transferrin receptor (TFN-R), HLA DR, Leu 8, and 
T -cell receptor beta chain were purchased from Becton Dickinson 
(Mountain View, CA); and anti BE2 MoAb was the gift of Dr. Carol 
Berger, (Columbia University, NY, NY). MoAb reactive with T-
cell receptor delta chain was purchased from T-Cell Sciences (Cam-
bridge, MA); and anti-CD25 (Tac) MoAb was the gift of Dr. 
Thomas Waldman (NIH, Bethesda, MD). Analysis was performed 
on the Ortho (Raritan, NJ) cytofluorograf with log amplification. 
N egative controls of goat anti-mouse FITC alone were routinely 
performed. Data shown do not subtract background. 
Cytogenetic Analysis Peripheral blood specimens were cul-
tured for 72-96 h with a mitogen combination consisting of phyto-
hemagglutinin (PHA), tetradecanol-0-phorbol-13-acetate (TPA), 
and interleukin 2 as previously described [8,9]. Standard trypsin-
Giemsa- banded chromosome preparations were made [9]. At least 
30 counts and 4 karyotype analyses were done to characterize the 
chromosomally abnormal clone. 
Cells of the SZ-4line were similarly processed without additional 
mitogenic stimulation. 
Southern Blot Analysis DNA from both SZ-4 PBMC or SZ-4 
cell line was extracted by cell lysis, proteinase K digestion, phenol 
extraction, and ethanol precipitation. Cellular DNA was digested 
with an excess of appropriate restriction enzymes, sized in 0.6% 
agarose gels, and transferred to nitrocellulose filters as described 
[10). A eDNA probe for the constant region of the human T cell 
receptor beta chain was used to detect rearrangements of the TCR-B 
locus [ 11]. The probe was labeled by nick translation (12], using one 
of several alpha-32P deoxycytosine triphosphates. Hybridization 
was carried out in 50% (voljvol) formamide, 4 X SSC (1 X SSC is 
0.15 M sodium chloride/0.015 M, pH 7.0), 0.2 mg of sonicated 
salmon sperm DNA/ml, 1 X Denhardt's solution (0.02% bovine 
serum albumin/0 .02% Ficoll/ 0.02% polyvinylpyrrolidone) at 
37 •c for 15 h. After hybridization, fi lters were washed for 30 min 
in pre-hybridization solution (as above) at 37 •c, followed serially 
by washes of 0.1 M KH 2P04 in 2 X SSC for 30 min at 65 • C and 
0.1 X SSC of 30 min at 65 · c. After drying, filters were exposed to 
Kodak XAR-5 fi lm with intensifying screens. 
IL-2 Responsiveness T o determine the responsiveness of this 
line to IL-2, varying amounts of riL2 were added to 5 X 104 SZ-4 
cel ls that were previously washed free of med ia in 96-well fl at-bot-
tom plates (Costar, Boston, MA) , which were cu ltured for 48 h at 
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Figure 1. The growth pattern of SZ-4 ce ll line over a 120-d period is 
depicted. Twenty-five million SZ-4 cells were placed in culture with 15 
U (ml r!L-2 and 0.2% CM until day 3; the cells were then cul tured with 
rlL-2 only. The arrows represent removal of cel ls from th e culture. (Re-
printed with permission from (24].) 
37 •c. [3H)-thymidine ([3H)-TdR) (Amersham, Arlington Heights; 
60 Ct/ mMol) was added for the final 6 h of cu lture using 2 ;tCi/ 
well and the cells harvested onto glass filtermats (Skatron, Lier, 
Norway) using a cell harvester (Flow, McLean, VA) . 
II~ IL-2 dependency experiments, SZ-4 ce lls were w ashed twice 
and mcubated at 37 • C for 45 min, then washed again to rid the cells I 
of any bound IL-2. The cell s were cultured for 48 h in 96-well 
flat-bottom plates as above, in media without IL-2 containing dilu-
twns of goat anti-human IL-2 (produced by Dr. P Wettstein , Wis-
tar Institute) varying from 1: 200 to 1: 125,000. [3H )-TdR was 
added to each well for the final 6 h of cu lture and harvested as above. 
Immunohist_ochemic~l Staining SZ~4 cell line T c~ll s w_ere \ 
processed for tmmunohtstochemtcal stammg by cytocentnfugatwn 
on glass slides and fixation in methanol : acetone (1: 1). After block· 
ing with 30% goat serum, cells were incubated with optimal con· 
centration of MoAb for 1 h, rinsed, and then developed with th( 
Dako (Santa Barbara, CA) alkaline phosphatase-anti-alkaline 
phosphatase (APAAP) kit. Briefly, linker antibody was added for 1 
h, then the APAAP immuno complex [13] was generated by subse· 
quem sequemial incubations. The AP substrate (napthol AS-MJ< 
phosphate and Fast Red) will yie ld a bright red positive reaction. 
Endogenous phosphatase was inhibited by levamisole contained in I 
the buffers. This technique allows the identification of one positive 
cell tn 104 cells due to the negligible background and dramatic color 
contrast between positive and negative cells [14). 
Immunoblotting (Western Blot Transfer) Immunoblotting 
was used to evaluate the presence of antibodies against HTLV-1 
proteins in patient serum as described [14). 
Lysates: Twenty million exponentially growing MT -2 cells, a 
~nown HTLV-I infected cell line, were pelleted and washed twice 
tn phosphate-buffered saline (PBS) without Mg++ and Ca++. The 
cel!s were lysed by the addition of2 mllysing buffer containing 1% 
TntonX100, 1 mMMgC1, 0.1 M Tris,pH 7.5, 1.0 mMdithiothre-
ttol, and 2.0 mM phenylmethylsulfonyl fl uoride. The cells were 
th~n gently vortexed followed by addition of equal volume of 2% 
Tnton lysmg buffer and a 2-h incubation on ice. The lysate was 
centrifuged at 15,000 rpm in a Spinco centrifuge for 30 min to 
remove cellular debris. 
Electrophoresis: Both commercially available purified HTLV -1 
proteins and lysate from MT -2 were separated by SDS-polyacrylam, 
ide gel electrophoresis using 10% acrylamide 20 V -8 mA/gel for 
16 h. After electrophoretic separation, proteins were transferred to 
nitrocellulose paper (Schleicher and Schuell , Keene , NH) in a 
Transblot (Biorad, Richmond , CA) at 60 V - 0.25 A for 4 h fo llow, 
ing manufacturer's instructions. The nitrocellulose sheet was cut Ul 
strips and washed with blocking buffer (20 mM Tris, 500 mM N aCl 
[pH 7.5), 3% gelatin) to saturate free binding sites and reacted for 60 
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Table I. Phenotypic Analysis of SZ-4 Blood and Cell Line 
C02 CD4 CDS CD3 CDS 
Blood 
11/85 74 55 19 
4/86 90 81 9 
Line 90 96 4 97 66 
min with anti-HTLV I antibody or SZ-4 serum. After thorough 
washing with 20 mM Tris, 500 mM NaCl, 0.05% Tween-20 
(TBS), strips were reacted with conjugate (peroxidase-labeled goat 
anti-mouse or anti-human IgG) for 1 h. Strips were washed again 
and developed for 10-15 min with freshly prepared solution con-
taining one part of 4-chloro-1-naphtol in methanol (0.3%), five 
parts of 100 mM Tris [pH 7.6] and H 20 2 to final concentration 
1:3000. This system can detect less than 100 ng of a specific pro-
tein. Strips with molecular weight markers are stained with ami-
doblack. 
Reverse Transcriptase Assay Reverse transcriptase activity was 
detected as performed by Poiesz et al [15] with poly A template, 
oligo(dT) primer in the presence of 10 mM Mg++. 
Electron Microscopy To determine morphologic characteris-
tics, either huffy coat preparations from the blood of patient SZ-4 or 
the SZ-4 cell line were processed for electron microscopy. Briefly, 
cells were fixed overnight at 40 oC with 2% glutaraldehyde (Elec-
tron Microscopy Sciences, Fort Washington, PA) in 0.1 M cacody-
late (Electron Microscopy Sciences), pH 7.4 (buffer), and then 
washed and post-fixed in 1% osmium tetroxide (Electron Micros-
copy Sciences) in buffer for 1 h, rinsed 2 times with buffer, dehy-
drated through graded ethanol to 100% and propylene oxide (Ladd, 
Burlington, VT) and embedded in Epon (Marivar, Nova Scotia). 
Thin sections were cut on an LK.B Ultrotime III, stained with ur-
onyl acetate and lead citrate, and viewed with a Hitachi HU-12A 
electron microscope. 
Analysis ofSZ-4 Genomic DNA for HTLV-1 Gag Sequences 
DNA Extraction: DNA was extracted from SZ-4 cell line by SDS/ 
proteinase-K digestion of cells fo llowed by phenol-chloroform ex-
traction in a nucleic acid extractor (Applied Biosystem, Inc.) The 
filter containing DNA was dissolved in double distilled water. 
DNA concentration were estimated by measuring the absorbance at 
260/280 nm. 
PCR: Two micrograms of DNA was amplified in 25 repetitive, 
three-step cycles for 1 min each at 95 o C and 55 o C, and for 2 min at 
72 °C. All amplifications were carried out in a Perkin-Elmer Cetus 
Thermal Cycler. Primer pairs were gag 841-864 bp, gag 1353-
1375 bp (HTLV-1 proviral sequence HLlPROP from gene bank); 
RM73 HTLV-I gag genomic DNA was used as a probe in this 
experiment. The 100 ,ul of PCR reaction mixture contained 2 ,ug of 
sample DNA, 278,uM each dATP, dCTP, dGTP, dTTP, 0.8,uMof 
each primer, 10 mM Tris (pH8.3), 50 mM KCl, 1.5 mM MgC12 , 
0.01% (w /v) gelatin (Sigma), and 2.5 units of Thermus Aquaticus 
polymerase (Taq) enzyme [1] (Perkin-Elmer, Cetus). The reaction 
mixture was overlayed with two drops of mineral oil to prevent 
evaporation and was denatured at 94 o C for 7 min before the Taq 
polymerase was added. 
Analysis of Amplified DNA for HTLV-I Gag Homology: Twenty-
five microliters of the final amplified reaction product was analyzed 
by electrophoresis on 1.2% agarose gel (150 v, 2-3 h) and trans-
ferred to Nitran nylon membrane (S&S Nitran) by blotting. The 
filter was soaked with 2 X SSC for 5 min at room temperature and 
baked at 80oC for 2 h under vacuum. The prehybridization buffer 
consists of 6 X SSC, 0.5%, SDS, 50% formamide, 5 X Denhardt's 
CD7 Leu8 TFN-R Dr Tac BE2 CD16 
38 38 60 95 97 97 7 
so~u~ion and 15_0 .Ug/ml h~rring sperm DNA. The filter was prehy-
brtd!zed overmght at 37 C and then hybridized overnight with 
12 X 106 cpm of labeled probe in prehybridization buffer. Filters 
were then washed with 2 X SSC and 0.1% SDS, two times for 20 
min at room temperature, then with 0.2 X X SSC, SDS, and 0.1% 
SDS for 20 min at room temperature, then 0.1 X SSC and 0.1% 
SDS for 30 min at 37 °C. Autoradiography was carried out with two 
intensifying screens (Cronen Hi Plans, Dupont) at -70° with 
Kodak X-AR film. 
RESULTS 
SZ-4 is a T-cellline established from the peripheral blood mononu-
clear cells of a patient with Sezary syndrome. To examine whether 
the cell line was dividing in culture, cell counts were performed. 
The growth characteristics of this cell line after stimulation with 
CM over a four-month period is depicted in Fig 1. The cell line 
appears to have a doubling time of approximately 30 h, which is 
maintained throughout the period shown. 
The phenotypic analysis of these cells performed months after 
initiation indicates that the cell line is a mature helper T cell ex-
pressing CD2, CD3, and CD.4 but not the cytotoxic/suppressor cell 
marker CDS (Table I). Th1s phenotype is characteristically ex-
pressed on the majority of atypical lymphocytes in blood of Sezary 
syndrome patients [16], and correlates well with the lymphocyte 
subset analysis performed on both the blood and the skin of patient 
SZ-4, with the exceptiOn of CD2. However, diminished CD2 ex-
pression on infiltrating T cells in the skin is not an uncommon 
occurrence (17]. The cell line also expresses a variety of activation 
markers including HLA-DR, transferrin receptors, CDS (T10), and 
CD 25 (Tac, light chain of the IL-2 receptor). In addition, these 
cells were positive with BE2, a monoclonal antibody that reacts 
with an activation antigen expressed on normal PHA blasts [18], 
whose reactivity has also been associated with Sezary cells [19]. The 
cel l line had partial reactivity with Leu 8 (38%), CD7 (Leu 9, 3A1 
(38%)), LFA1 (60%), and anti-beta TCR antibody (41 %) , but was 
BamH I 
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Figure 2. DNA extracted from SZ-4 cel l line (CL) and the patient's PBMC 
(PB) were subjected to Southern blot analysis using a probe for the C-beta 
region of the TCR. Bam H1-digested DNA show the germ line band (gl) at 
22.6-kb and a 1 0-kb rearrangement in both the blood and cell line. The 
blood an~ cell line provide germline configurations in the Eco Rl-digested 
DNA. Hmd 1Il d1gest10n produced a 7-kB fragment in the DNA from both 
cell line and blood. (Reprinted with permission from (24].) 
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Figure 3. Transmission e lectronmicros~opy of a typical Sezary T cell from the peripheral blood buffy coat prior to culture (A), compared to cultured cells of 
SZ-4 line (8-D). Note the elaborately mfolded nuclear contour of a pre-culture Sezary cell (A), and retention of these contour anomalies by some of the 
cultured cells from this patient (B -D). Occasional cells in the SZ-4line were multinucleated (syncytia-like cells); some contained numerous mitochondria and 
cistternae of smooth endoplasmic reticulum (C, D) and clusters of aberrant centrioles centrally located within the cytoplasm (D). A: bar, 1/f.m. B: bar, 1/f.m. C: 
bar, 5 ,um. D: bar, 5 )lm (inset bar, 1 ,urn) . 
found negative for CD 16 (NK marker) and CD 20 (B cell marker) 
and TCR delta chain. 
Chromosome studies were originally performed on a blood speci-
men obtained in December 1985. At that time the patient's total 
leukocyte count was 8,800 (54% lymphocytes, 22 Sezary cells/100 
lymphocytes). A pseudodiploid clone with multiple cytogenetic 
abnonnalities was found, with the karyotype partially characterized 
as: 46,XX, 1p-, 4q-, +?4q-, abn 5, -10, 16q+, iso (17q], -18, 
21q+, +mar. 
A repeat study was performed on the blood in January 1987. 
Several related near-diploid subclones were present with a number 
of the same karyotypic alterations (e.g., lp-, 16q+, iso [17q], 
21q+) still present, as well as additional changes (e.g. 3q-, 6q-), 
consistent with the patient's clinical progression. In both blood 
studies, a very small number of near-tetraploid meta phases ( < 3%) 
was observed. 
Cytogenetic data on the SZ-4 cell line, established in September 
1986, were first obtained in November 1986 (day 64). Approxi-
mately half of the metaphases were normal, and the remainder 
constituted a near-tetraploid clone with many of the same structural 
chromosome abnormalities observed in lymphocytes from the 
blood: 1p-, 3q-, 4q-, 16q+, iso [17q], 21q+. The cell line was 
reexamined in December 1987 (day 451), and although only a few 
usable metaphases were obtained, they all appeared to represent the 
same near-tetraploid clone. 
To confirm the observation made by cytogenetic analysis, ~e 
subjected DNA extracted from the cell line and the patient's PBMC 
to Southern blot analysis using a probe for the C-beta region of the 
TCR gene as described in Materials and Methods. Results in Fig 2 
show that cells from both of these sources contain similar clonal 
rearrangements . Bam Hl-digested DNA show a 10-kb rearranged 
band found in both the blood and cell line. Hind III digestion 
produced a 7-kb rearranged band in the DNA from both cellliue 
and blood. These data indicate that both the cell line and blood 
contain a clone with a unique TCR rearrangement that produces 
identically sized fragments in Bam HI and Hind III digestions. 
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Figure 4. T he thymidine (TdR) incorporation of SZ-4 (closed circle) and 
CTLL (open circle) celllmes to a titratiOn of r!L-2 1s shown m A. SZ-4 cell 
line was cultured in medium without IL-2 for 48 h before initiation of the 
experiment. IL-2- dependcnt CTLL cells removed from a rapidly growing 
culture were used as an IL-2-dependent control. Cells were cultured as 
described in Materials a11d Methods with 5 X 104 ce lls/wel l in 200-,ul volume 
in flat-bottom 96-well plates. Cells were cultured for 40 h, with 2 uCi 
' 1-I-TdR provided fo r the last 4 h of culture. Data shown represent the mean 
of triplicate cultures. B shows the effect of anti - IL-2 antisera on the prolifer-
ation ofCTLL (opeu circle) and SZ-4 cell line (closed circle). CTLLcells taken 
from an IL-2 -dependent culture were given 12.5 U / ml riL-2 and various 
concentrations of goat anti-human IL-2. SZ-4 cells were taken from a cul-
ture deprived of r!L-2 for 48 h and then cultured without riL-2, along with 
various concentrations of the goat anti- IL-2 antisera. Five X 104 cells/ well 
from each cell line were cultured for 48 h, with 2 uCi 3 1-I TdR provided for 
the final 4 h. Data represent the mean of triplicate cultures. Response ofSZ-4 
cell line when given 15 U/ ml riL-2 in th is experiment was 239,610 (cpm). 
(Reprinted with permission from (24].) 
Migration patterns such as these have been interpreted by others as 
signifying identical clones (20,21 ]. 
Sezary cells observed in the peripheral blood typically contain 
convoluted nuclei [22]. The morphologic characteristics of a typical 
Sezary cell fro m the peripheral blood of patient SZ-4 (Fig 3A) and 
several of th e T cells in SZ-4 cell line (Fig 3 B, C, D) are shown in 
the electron micrographs in Fig 3. Many of the cells observed in the 
cell line are moderately convoluted in contour, an example of which 
is shown in B. Such cells were indistinguishable from Sezary cells in 
the peripheral blood. However, not all cultured cells had convo-
luted nuclei, which may relate to in vitro conditions. Approxi-
mately 5% of the ce lls contained multiple nucleiC, D), and aberrant 
mitoses and centriol es were documented in occasional cells (D, 
inset). 
Because T-cell dependence on IL-2 for growth is a hallmark of 
normal, but not necessarily of tumor, cells (23], we wished to deter-
mine ifSZ-4 was dependent on IL-2 for its continuous proliferation. 
To investigate the IL-2 requirements of this cell line, we performed 
a titration of riL-2. Figure 4 (A ) contains data demonstrating that 
the line is responsive to IL-2 but continues to synthesize DNA, as 
measured by thymidine incorporation, w ith no IL-2 present. Data 
with CTLI, an IL-2 - dependent line, are also shown. To confirm 
the IL-2 independence of SZ-4 and to eliminate the possibility that 
the line is itself producing enough IL-2 to stimulate the cell division 
in an autocrine fashion (observed in th e "no IL-2" group), we cui -
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tured th e line for 2 d without IL-2 and then with varying concen-
trations of goat anti-human IL-2 in media without rlL-2. The data 
in Fig 4 (B) show that the cell line is not affec ted by the antiserum. 
In addition, conditioned media from SZ-4 cells grown without IL-2 
for 3 d were found devoid of IL-2 when tested in a CTLI assay, 
suggesting that SZ-4 line does not constitutively produce IL-2 (data 
not shown). T aken together, these data indicate that this cell line 
can proliferate in an IL-2 - independent manner. 
Because the cell line demonstrated IL-2 independence and be-
cause HTL V -1 infection has been observed w ith some patients with 
CTCL, w e tested serum from this individual for reactivity against 
pure HTL V-I proteins on a Western blot. Reactivity against an 
HTLV -I gag protein (p24) was observed, but little or no reactivity 
against the env or other mature proteins was found (data not 
1353 
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603-
310-
281 
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194 
1 2 3 4 
Figure 5. Analysis ofSZ-4 amplified with HTLV-1 gag primer pairs. Two 
micrograms of SZ-4 genomic DNA was amplified for 25 cycles as described 
in Materials a11d Methods and analyzed for HTLV -I gag sequence (la11e 4) . The 
PCR product was analyzed after sizing in a 1.2% agarose gel by hybridiza-
tion to a labeled HTLV-1 gag probe; autoradiography was then performed. 
Either 20 or 2 ng of DNA from a known HTLV-I - infected cell line (13-4) 
was amplified as a positive control (la11es 1-3). Two micograms of genomic 
DNA from 7 healthy donors was also found negative for HTLV-1 gag 
sequences (not shown). Primer pairs used in this experiment were gag 841-
864 bp, gag 1353-1375 bp (HTLV-1 proviral sequence HLtPROP from 
gene bank) , and HTLV-1 gag genomic probe. 
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shown). These results are considered negative for HTL V-I infec-
tion. In addition, SZ-4 was tested for expression of the gag proteins 
p 19 and p24 and env protein gp46 using the alkaline phosphatase 
anti-alkaline phosphatase (APAAP) system. The cell line did not 
express either p24 or gp 46 HTLV-I proteins (data not shown). 
Furthermore, cu lture supernatants were found devoid of reverse 
transcriptase activity (data not shown). 
To confirm the lack of HTLV -I infection in this line, we per-
formed polymerase chain reaction (PCR) amplification ofSZ-4 ge-
nomic DNA as described in Materials a11d Methods. After extraction, 
2 ,ug SZ-4 genomic DNA was amplified utilizing HTLV-I gag 
primers for 25 cycles and then analyzed for hybridization to .an 
HTLV-1 gag-genomic probe. Results shown in Fig 5 indicate that 
SZ-4 does not contain HTL V-I gag sequences (lane 4), as compared 
to the amplified product generated from either 200-, 20-, or 2-ng 
genomic DNA from a known HTLV-1-infected cell line (13-4) 
(lanes 1-3). Taken together, we conclude that neither the SZ-4 
patient nor the cell line were HTLV-1 infected. 
DISCUSSION 
W e have shown that a long-term T -cell line has been established 
that contains T cells with identical morphologic, phenotypic, and 
genotypic features as those found in the blood of a patient with 
Sezary syndrome. The line expresses the normal helper T -cell 
markers CD2, CD3, CD4, and activation antigens HLA-DR, trans-
ferrin receptors, BE2, and Tac. To our knowledge, this is the first 
non- HTL V-I transformed Sezary T -cell line to express all these 
antigens and to be derived from the neoplastic clone. 
In order to examine whether the cells in culture resembled mor-
phologically the Sezary cells in the peripheral blood, electron mi-
croscopy was performed. Many of the cells in the SZ-4 cell line were 
morphologically indistinguishable from the Sezary cells in the pa-
tients' bl.ood. Cells in the SZ-4 cell line with slightly convoluted 
nuclei, although similar in both size and overall morphology to the 
cells with moderately convoluted nuclei in the culture, may repre-
sent either normal cells remaining in the culture or Sezary cells that 
have lost their convoluted nuclei in culture. If the latter is true, this 
in vitro model could provide a means to investigate how nuclear 
morphology is regulated. 
To determine if the T cells in our culture were derived from 
malignant (Sezary) cells in the blood of the patient, we compared 
the karyotype and genotype of cells from these two sources. Results 
from these analyses show that both the patient's circulating lympho-
cytes and the cell line share a number of specific chromosomal 
abnormalities and also have an identical TCR gene rearrangement, 
strongly supporting the concept that the cells in culture were de-
rived from the Sezary cell clone in the blood. Interestingly, the 
predominant neoplastic cells in culture had a near-tetraploid karyo-
type, whereas in the blood a near-diploid clone was predommant, 
with rare hypotetraploid cells in these chromosome preparations. In 
many Sezary patients, the circulating neoplastic clone is a mixture of 
diploid and tetraploid subpopulations [8,9], with proportions vary-
ing at different times. There are at least two possible explanations 
for the differences between the karyotypes observed in the blood 
and in the cell line. First, the cell line was derived from the hypote-
traploid subclone observed in the blood, which in turn was derived 
from the pseudodiploid clone in vivo at a time before the aterations 
to chromosomes 5, 10, and 18 occurred. Alternatively, the hypote-
traploid clone grown in vitro was derived from the pseudodiploid 
clone in vivo; the karyotypic differences between the line and blood 
represent changes that occurred in culture. It is not clear why the 
hypotetraploid clone grew more readily in our culture conditions. 
Another aspect of this cell line that suggests in malignant neo-
plastic origin is its ability to proliferate in an IL-2 - independent 
manner. The entry of normal T cells from G 1 to S phase of the cell 
cycle is dependent upon interaction with either endogenous or exog-
enous IL-2, along with other signals [25- 30] . Loss of the require-
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ment for these signals can be observed with aggressive T -cell tumors 
such as adult T -cell leukemia and suggests that the cells are trans-
formed. Two types of transforming agents for human T cells are the 
retroviruses HTLV I and II [23] . Although the patient's serum con-
tains antibodies that react with HTL V-I p24 gag protein, reactivity 
was not observed with products from any of the other genes, includ-
ing any mature envelope proteins, and therefore must be considered 
negative. Because the HTL V-I proteins used in this assay also cross-
react immunologically with HTL V II, this patient can be consid-
ered seronegative for this virus as well. In addition, the cell line does 
not express either p24 gag, p46, or p62 env HTL V-I antigens, nor 
does it have reverse-transcriptase activity. Furthermore, we were 
unable to detect the HTL V-I gag gene in amplified SZ-4 cell line 
DNA. Taken together, it is unlikely that this patient or her cell line 
is infected with HTLV-I or II. 
Success in establishing this line may relate to the method we used 
to initiate the culture, and/or to the aggressive nature of this tumor 
clone. The clinical status of this individual at the time blood was 
drawn for culture suggests that her tumor was an aggressive variant. 
This line was established by the addition of mitogen-conditioned 
media made with Sezary PBMC to the PBMC of this patient. CM 
generated with PBMC from healthy donors could not substitute for 
Sezary-derived CM. However, in preliminary experiments, we 
found that some, but not all, PBMC from other Sezary patients 
appeared to have similar activity. SZ-1 CM appears to contain a 
potentially novel factor that we have called Sezary Activating Fac-
tor (SAF), which induced functionaliL-2R on these cells. • As we 
and others have failed to grow Sezary tumor cells in culture through 
the addition of mitogens [2- 6], SAF may activate Sezary cells 
through a different pathway than that util ized by mitogens. 
The long-term Sezary T -cell line described here may prove useful 
in understanding the nature of this disease through examination of 
its responsiveness to, and production of, lymphokines and cyto-
kines. Although the chromosomal abnormalities in patients with 
Sezary syndrome appear to be largely random [9], analysis of the 
specific abnormalities found in this clone may provide clues to its 
growth advantage and interleukin independence. In addition, deter-
mination of the specific V-region family used in this clone's T-cell 
receptor compared to that used in other cases of Sezary syndrome 
may provide clues as to whether a subtype ofT cell, or a specific 
antigen, is involved in this disease . 
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